PPD claims new software will expedite clinical data review

By Kirsty Barnes

- Last updated on GMT

PPD International has launched a new software system that it claims
can speed up the review time of safety and endpoint-driven data
from large-scale clinical trials or registries.

The software is particularly useful for expediting independent board review of large-scale safety trial data, said the firm.

The GlobalView EventNet is an event management and adjudication system that has been built on PPD's current electronic data capture (EDC) technology and provides access to safety events contained within clinical and/or safety databases.

PPD said the advantage of the new system is that it provides access through an online interface to near real-time data and source documents, enabling the information to be reviewed at any time in any global location.

"The secure Internet, network-based system accelerates review of data, particularly when studies with multiple sources of information on individual patients require review by a board of independent physicians,"​ said a company statement.

"The system can also accommodate multiple event adjudication boards within the same study,"​ said Susan Atkinson, vice president of biostatistics and data management for PPD.

Through an online interface, review board members can request follow-up information or confirm adjudicated events.

The system electronically compares the results of each board member's decision and appropriately documents decisions according to established guidelines.

Other features of the technology include online tracking of safety events, status reporting for activities and e-mail alerts to prompt and encourage timely review.

"In addition, the GlobalView EventNet can be customised to work with clients' data management systems,"​ said Atkinson.

"When coupled with our EDC and pharmacovigilance software, the technology enables us to streamline and expedite this critical component of the drug or device development process."

The use of eClinical software in clinical trials is rapidly gaining in popularity with pharmaceutical, biotechnology and contract research organisations (CROs) as they strive to increase efficiencies in data capture, management and analysis and dramatically speed up this predominantly manual and cumbersome aspect of clinical trials.

Related news

Show more

Related products

show more

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers